Journal
CURRENT OPINION IN RHEUMATOLOGY
Volume 34, Issue 1, Pages 18-24Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/BOR.0000000000000852
Keywords
biomarker; imaging modalities; large vessel vasculitis; management; Takayasu arteritis
Categories
Ask authors/readers for more resources
This review summarizes recent advances in Takayasu arteritis (TAK), focusing on pathogenesis, imaging modalities, and management. Three novel clusters based on angiographic findings were identified and replicated in different cohorts. New imaging modalities have shown promising results in assessing arterial inflammation. There is more evidence on the long-term use of tocilizumab, but relapses are common. Janus kinase inhibitors seem to be promising based on recent findings. Improvements in imaging modalities and understanding of disease pathogenesis will enhance disease assessment and identification of effective therapies.
Purpose of review The purpose of this review is to summarize the recent advances in Takayasu arteritis (TAK), mainly focusing on pathogenesis, imaging modalities, and management. Recent findings Three novel clusters based on angiographic findings were identified in the Indian cohort and replicated in the North American cohorts. Different new imaging modalities have been tried in the assessment of arterial inflammation with promising results. There is more evidence on the long-term use of tocilizumab, but relapses are common. In light of the recent findings on the pathogenesis of TAK, Janus kinase inhibitors seem to be promising. Summary Improvement in imaging modalities and in our understanding of the disease pathogenesis will allow us to better assess the disease activity and identify effective therapeutic agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available